Skip to search.
New User?
Register
Sign In
Help
Get new Yahoo! Mail apps
Notifications
Help
Mail
My Y!
Yahoo!
Yahoo! Finance
Search
Search Web
Breaking News
Visit Yahoo! News for the latest.
×
Close this window
HOME
INVESTING
Market Overview
Market Stats
Stocks
Mutual Funds
ETFs
Bonds
Options
Industries
Currencies
Education
Commodities
NEWS
Markets
Investing Ideas
Special Editions
Company Finances
RSS Feeds
Video
Photos & Interactives
PERSONAL FINANCE
Career & Education
Insurance
Lifestyle
Loans
Real Estate
Retirement
Saving & Spending
Taxes
Glossary
Your Money 101
MY PORTFOLIOS
Sign in to access My Portfolios
Free trial of Real-Time Quotes
EXCLUSIVES
Breakout
The Daily Ticker
The Exchange
Unexpected Returns
Financially Fit
Just Explain It
Hot Stock Minute
CNBC
Big Data Download
Off the Cuff
Talking Numbers
Latest Headlines
Search for share prices
Search for share prices
Finance Search
Wed, May 22, 2013, 5:15AM EDT - U.S. Markets open in 4 hrs 15 mins
Dow
0.34%
Nasdaq
0.16%
More On LOR.TO
Quotes
Summary
Order Book
Options
Historical Prices
Charts
Interactive
Basic Chart
Basic Tech. Analysis
News & Info
Headlines
Press Releases
Company Events
Message Boards
Market Pulse
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Components
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Ownership
Major Holders
Insider Transactions
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Lorus Therapeutics Inc. (LOR.TO)
-
Toronto
0.23
0.01(2.17%)
May 21
Add to Portfolio
Press Releases
Get Press Releases for:
Wednesday, April 17, 2013
Lorus Therapeutics Signs Research and License Option Agreement with Elanco
Marketwired
( (Wed, Apr 17)
Lorus Therapeutics Signs Research and License Option Agreement With Elanco
GlobeNewswire
( (Wed, Apr 17)
Lorus Therapeutics Signs Research and License Option Agreement with Elanco
Marketwired
( (Wed, Apr 17)
Friday, April 12, 2013
Lorus Therapeutics Reports Third Quarter Results for Fiscal Year 2013
Marketwired
( (Fri, Apr 12)
Lorus Therapeutics Reports Third Quarter Results for Fiscal Year 2013
Marketwired
( (Fri, Apr 12)
Wednesday, April 10, 2013
Lorus Therapeutics Announces Presentation of Biomarker Data for LOR-253 at 2013 AACR Annual Meeting
GlobeNewswire
( (Wed, Apr 10)
Tuesday, March 5, 2013
Lorus Therapeutics Announces Allowance of Chinese Patent for Anticancer Drug LOR-253
Marketwired
( (Tue, Mar 5)
Lorus Therapeutics Announces Allowance of Chinese Patent for Anticancer Drug LOR-253
Marketwired
( (Tue, Mar 5)
Tuesday, February 12, 2013
Lorus Therapeutics to Present LOR-253 Data at 2013 AACR Annual Meeting
Marketwired
( (Tue, Feb 12)
Lorus Therapeutics to Present LOR-253 Data at 2013 AACR Annual Meeting
Marketwired
( (Tue, Feb 12)
Tuesday, January 22, 2013
Lorus Therapeutics Announces Issuance of United States Patent for Cancer Therapy IL-17E
Marketwired
( (Tue, Jan 22)
Lorus Therapeutics Announces Issuance of United States Patent for Cancer Therapy IL-17E
Marketwired
( (Tue, Jan 22)
Monday, January 14, 2013
Lorus Therapeutics Reports Second Quarter Results for Fiscal Year 2013
Marketwired
( (Mon, Jan 14)
95993774